Virgin Orbit information for Chapter 11 individual bankruptcy protection in the U.S.

Virgin Orbit information for Chapter 11 individual bankruptcy protection in the U.S.


The firm’s modified 747 jet “Cosmic Lady” in Mojave, California.

Virgin Orbit

Virgin Orbit on Tuesday filed for Chapter 11 personal bankruptcy safety in the U.S. following failing to protected a funding lifeline.

The California-based mostly satellite start organization lodged the filing in the U.S. Bankruptcy Court in the District of Delaware and is looking to sell its belongings.

It arrives following CNBC attained audio of Virgin Orbit CEO Dan Hart telling workers all through an all-palms meeting last week that the business was ceasing functions “for the foreseeable long term.” The business also stated it would lay off almost all of its workforce.

“While we have taken good endeavours to address our monetary situation and safe extra financing, we in the end need to do what is most effective for the small business,” Hart stated in a assertion Tuesday.

“We consider that the cutting-edge launch engineering that this group has produced will have vast appeal to customers as we go on in the method to market the Business. At this stage, we think that the Chapter 11 procedure signifies the best route ahead to discover and finalize an effective and price-maximizing sale,” he added.

Virgin Orbit mentioned Virgin Investments would give $31.6 million in new funds by means of debtor-in-possession financing to enable fund the process and defend its operations.

Virgin Orbit produced a method that utilizes a modified 747 jet to mail satellites into room by dropping a rocket from under the aircraft’s wing mid-flight.

The firm’s very last mission experienced a mid-flight failure, with an difficulty through the start indicating the rocket did not get to orbit and crashed into the ocean.

Virgin Orbit is among a pick out several U.S. rocket organizations to properly obtain orbit with a privately formulated start vehicle. It has released six missions since 2020, with 4 successes and two failures.

It has been seeking for new funds for quite a few months, with the vast majority proprietor Richard Branson unwilling to fund the business further.

“Right now my ideas and concerns are with the numerous talented teammates and buddies now acquiring their way forward who have been fully commited to the mission and guarantee of all that Virgin Orbit signifies,” Hart mentioned.

“I am confident of what we have designed and hopeful to attain a transaction that positions our Organization and our know-how for long run chances and missions,” he included.

— CNBC’s Michael Sheetz contributed to this report.



Resource

OpenAI announces GPT-5.5, its latest artificial intelligence model
World

OpenAI announces GPT-5.5, its latest artificial intelligence model

OpenAI CEO Sam Altman during a media tour of a Stargate AI data center in Abilene, Texas, Sept. 23, 2025. Bloomberg | Bloomberg | Getty Images OpenAI on Thursday announced its latest artificial intelligence model, GPT-5.5, which the company says is better at coding, using computers and pursuing deeper research capabilities. The launch comes less […]

Read More
Software stocks plunge on ServiceNow, IBM results as AI fears escalate
World

Software stocks plunge on ServiceNow, IBM results as AI fears escalate

Signage outside the ServiceNow headquarters in Santa Clara, California, US, on Thursday, Sept. 4, 2025. David Paul Morris | Bloomberg | Getty Images Software stocks plummeted on Thursday as disappointing results from ServiceNow and IBM added to fears that artificial intelligence tools and services will disrupt their businesses. Shares of ServiceNow sank 17% Thursday, on […]

Read More
Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
World

Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment

Roche reported falling sales in the first three months of the year, as the strength of the Swiss franc and generic competition for some of its older drugs weighed on the drugmaker.  First-quarter sales came in at 14.7 billion Swiss francs ($18.7 billion), down 5% year-on-year — but up 6% on a constant currency basis. […]

Read More